'Assessing QbTest Utility in ADHD' (AQUA) is an NIHR CLAHRC East Midlands trial with MindTech providing clinical leadership (PI: Prof Chris Hollis) and technological support. The project arose out of the MindTech partnership with the SME QbTech Ltd.

The aim is to assess in a randomised controlled trial (RCT) whether providing clinicians and patients with the results of an objective test of activity and attention (QbTest) leads to earlier correct diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD). A secondary objective is to assess whether the QbTest leads to earlier optimisation of treatment and improved patient outcomes in ADHD in routine NHS settings.

More information: http://www.clahrc-em.nihr.ac.uk/clahrc-em-nihr/research/enhancing-mental-health/index.aspx

See publications page for the published protocol in BMJ Open (Trial registration number NCT02209116).

Join MindTech (click)

We would love to keep in touch with you regarding our work and how you might be able to help. Please fill in this form so we can contact you.

Have you had your say yet? Tell us your top 3 research questions about digital for mental health… https://t.co/5IVZ929SuE

What if tech tried to be healing instead of just addictive? Interesting article about designing wellbeing into tech https://t.co/yOlYVF6f2v